Senti Biosciences, Inc. / Fundamentals
Income statement
- Net revenue
€5.02M - Cost of goods sold
€3.78M - Gross profit
€1.25M - SG&A expenses
€25.05M - R&D expenses
€30.69M - EBITDA
-€41.26M - D&A
-€1.25M - EBIT
-€55.41M - Interest expenses
€0.00 - EBT
-€50.04M - Tax expenses
€0.00 - Net income
-€50.04M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€8.06M - Changes in working capital
-€3.29M - Operating cash flow
-€41.61M - Capex
€177.61K - Other investing cash flow
€51.48K - Net investing cash flow
-€115.83K - Total cash dividends paid
€0.00 - Issuance of common stock
€42.95M - Debt repayment
€0.00 - Other financing cash flow
€45.75M - Net financing cash flow
€46.61M - Foreign exchange effects
€17.16K - Net change in cash
€4.91M - Cash at end of period
€18.51M - Free cash flow
-€41.43M
Balance sheet
- Cash and cash equivalents
€18.51M - Cash and short-term investments
€18.51M - Total receivables
€3.17M - Inventory
€0.00 - Other current assets
€6.22M - Total current assets
€27.90M - Property, plant & equipment
€27.83M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€3.03M - Other non-current assets
€44.62K - Total non-current assets
€30.90M - Total assets
€58.81M - Accounts payable
€875.16K - Short-term debt
€4.27M - Other current liabilities
€3.11M - Total current liabilities
€8.57M - Long-term debt
€45.19M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€6.49M - Total non-current liabilities
€29.09M - Total liabilities
€37.66M - Common stock
€2.57K - Retained earnings
-€279.69M - Other equity
€0.00 - Total equity
€21.15M - Total liabilities and shareholders' equity
€58.81M
Company information
- Market capitalization
€48.05M - Employees
34 - Enterprise Value
€71.93M
Company ratios
- Gross margin
-
24.8% Much better than peer group: -609.0% - EBITDA margin
-
-821.3% Much better than peer group: -331,177.6% - EBIT margin
-
-1,102.7% Much better than peer group: -14,927.8% - EBT margin
-
-995.9% Much better than peer group: -14,477.8% - Net margin
-
-995.9% Much better than peer group: -14,364.2% - ROE
-
-236.6% Much better than peer group: -1,631.2% - ROA
-
-85.1% Much better than peer group: -596.8% - Asset turnover
-
8.5% Much better than peer group: -1,218.6% - FCF margin
-
-831.6% Much better than peer group: -10,977.4% - FCF yield
-87.0% - Efficiency ratio
921.3% - Net sales per employee
-
€147.78K - Net income per employee
-
-€1.47M